MX2021005755A - Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo. - Google Patents

Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo.

Info

Publication number
MX2021005755A
MX2021005755A MX2021005755A MX2021005755A MX2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A
Authority
MX
Mexico
Prior art keywords
oxidative stress
roxp
compositions
skin diseases
skin
Prior art date
Application number
MX2021005755A
Other languages
English (en)
Inventor
Rolf Lood
Original Assignee
S Biomedic N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Biomedic N V filed Critical S Biomedic N V
Publication of MX2021005755A publication Critical patent/MX2021005755A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7004—Stress
    • G01N2800/7009—Oxidative stress

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)

Abstract

La presente solicitud se refiere al uso de composiciones que comprenden una cepa viva de C. acnes que secreta RoxP (radical oxigenasa de Propionibacterium acnes) y composiciones que comprenden RoxP o una variante biológicamente activa o fragmento de la misma para el tratamiento o prevención de enfermedades de la piel asociadas al estrés oxidativo o para la prevención o reducción de envejecimiento de la piel; la solicitud se refiere además a un método para el diagnóstico de enfermedades de la piel asociadas a estrés oxidativo en un sujeto o para la determinación del beneficio que recibiría un sujeto de la administración de RoxP o una cepa viva de C. acnes que secreta RoxP, los métodos comprenden determinar la cantidad de RoxP o la cantidad de C. acnes en una muestra de piel del sujeto.
MX2021005755A 2018-11-16 2019-11-15 Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo. MX2021005755A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18206646 2018-11-16
PCT/EP2019/081546 WO2020099663A1 (en) 2018-11-16 2019-11-15 Compositions for treating oxidative stress-associated skin diseases and skin ageing and diagnosis of oxidative stress-associated skin diseases

Publications (1)

Publication Number Publication Date
MX2021005755A true MX2021005755A (es) 2021-08-11

Family

ID=64331864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005755A MX2021005755A (es) 2018-11-16 2019-11-15 Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo.

Country Status (10)

Country Link
US (1) US20220000762A1 (es)
EP (1) EP3880304A1 (es)
JP (1) JP7532361B2 (es)
KR (1) KR20210094576A (es)
CN (1) CN113038959B (es)
AU (1) AU2019380669A1 (es)
BR (1) BR112021008496A2 (es)
CA (1) CA3118524A1 (es)
MX (1) MX2021005755A (es)
WO (1) WO2020099663A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017521059A (ja) 2014-06-17 2017-08-03 ザイクローブ セラピューティクス, インク.Xycrobe Therapeutics, Inc. 機械的に位置合わせされた光学的要素及びその製造方法
CA3021690A1 (en) 2015-04-20 2016-10-27 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
ES2967029T3 (es) 2016-10-19 2024-04-25 S Biomedic Nv Métodos y composiciones para cambiar la composición del microbioma de la piel usando mezclas complejas de cepas bacterianas
AU2021297215A1 (en) * 2020-06-23 2023-02-09 Crown Laboratories, Inc. Probiotic skin formulations
CN113219097B (zh) * 2021-01-15 2022-06-24 杭州海关技术中心 婴幼儿配方奶粉中肉碱对映体拆分和测定方法
AU2022416748A1 (en) * 2021-12-17 2024-06-13 S-Biomedic A freeze-dried composition and preparation thereof
EP4197523A1 (en) * 2021-12-17 2023-06-21 DSM IP Assets B.V. A freeze-dried composition and preparation thereof
WO2023135186A1 (en) * 2022-01-12 2023-07-20 S-Biomedic Nv Skin care composition and uses thereof
CN115165819B (zh) * 2022-05-27 2024-08-09 天津科技大学 一种快速定量分析芦丁的荧光分子印迹光子晶体凝胶条的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP2011037764A (ja) * 2009-08-11 2011-02-24 Shiseido Co Ltd 皮膚外用剤、美白剤、抗酸化剤および抗老化剤
FR2954140A1 (fr) * 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
ITPR20110035A1 (it) 2011-05-06 2012-11-07 Bormioli Rocco & Figlio Spa Capsula.
ITUA20162141A1 (it) 2016-03-31 2017-10-01 Bormioli Pharma Spa Capsula di chiusura
IT201600097495A1 (it) 2016-09-28 2018-03-28 Bormioli Pharma S R L Capsula con struttura di contenimento e rilascio di un prodotto
ES2967029T3 (es) 2016-10-19 2024-04-25 S Biomedic Nv Métodos y composiciones para cambiar la composición del microbioma de la piel usando mezclas complejas de cepas bacterianas

Also Published As

Publication number Publication date
CN113038959B (zh) 2024-09-13
AU2019380669A1 (en) 2021-05-20
WO2020099663A1 (en) 2020-05-22
US20220000762A1 (en) 2022-01-06
JP7532361B2 (ja) 2024-08-13
BR112021008496A2 (pt) 2021-08-10
EP3880304A1 (en) 2021-09-22
CN113038959A (zh) 2021-06-25
KR20210094576A (ko) 2021-07-29
JP2022507616A (ja) 2022-01-18
CA3118524A1 (en) 2020-05-22

Similar Documents

Publication Publication Date Title
MX2021005755A (es) Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo.
PH12020551038A1 (en) Compositions comprising co-selected microbiota and methods for use thereof
MX2020013557A (es) Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y métodos de uso del mismo.
MX2022004051A (es) Composicion novedosa para el cuidado de la piel.
IN2015DN00376A (es)
PH12018500762A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
ZA201902384B (en) Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same
JP2016516985A5 (es)
MX2022004052A (es) Composicion novedosa para el cuidado de la piel.
MX2022004056A (es) Composicion novedosa para el cuidado de la piel.
JP2015500820A (ja) Ｅｇｆｒ阻害の有害反応を予防または処置するための組成物
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
ZA202001568B (en) Methods and compositions for treating chronic lung diseases
MX2022004055A (es) Composicion novedosa para el cuidado de la piel.
WO2019098759A3 (ko) 형질전환된 인간세포 및 이의 용도
AU2014352875A8 (en) Gastrin antagonists (eg YF476, netazepide) for treatment and prevention of osteoporosis
MX2021009247A (es) Metodos, sistemas y kits para tratar enfermedades inflamatorias que se dirigen a il18r1.
MX2018011539A (es) Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas.
WO2019055776A3 (en) Compositions and methods for treatment of diseases involving cxcl1 function
MX2022004050A (es) Composicion novedosa para el cuidado de la piel.
MX2021003798A (es) Terapia con celulas de placenta humana y celulas hematopoyeticas.
WO2020018949A3 (en) Methods and compositions for microbial engraftment
BR112016028561A2 (pt) composição, forma de dosagem, e, métodos para reduzir o risco para mortalidade em um indivíduo, o risco para uma doença ou condição em um indivíduo, triglicerídeos em um sangue de indivíduo, a frequência cardíaca em repouso de um indivíduo, o colesterol de lipoproteína de densidade não alta em um indivíduo, o colesterol total em um indivíduo, a apolipoproteína b em um sangue de indivíduo, pressão sanguínea sistólica em um indivíduo e a pressão sanguínea diastólica em um indivíduo, para prolongar a vida de um indivíduo, para tratar hipertrigliceridemia em um indivíduo e para aumentar um índice de ômega-3 em células vermelhas do sangue de um indivíduo.
MX2020003682A (es) Metodos para tratar enfermedades asociadas con ciliopatias.